Johnson & Johnson
Kathy Wengel is Executive Vice President & Chief Global Supply Chain Officer for Johnson & Johnson, and a member of the company’s Executive Committee. A strong developer of globally diverse teams, she leads a Supply Chain organization that brings healthcare products and services to more than a billion patients and consumers around the world every day.
Kathy leads all aspects of Supply Chain across Johnson & Johnson’s three business sectors: Consumer Health, Medical Devices and Pharmaceuticals. Her responsibilities include enterprise Supply Chain strategy, innovation and deployment, planning, sourcing, manufacturing, distribution and customer service. She also has corporatewide responsibility for Quality & Compliance; Environmental Health, Safety & Sustainability; and Engineering & Property Services, including Real Estate, Facilities and Capital Project Management.
Since joining Johnson & Johnson in 1988, her responsibilities have grown to include a variety of strategic leadership and executive positions across the enterprise, working in multiple countries and roles within operations, quality, engineering, new product development and other business functions.
Prior to Kathy’s current role, she was Vice President, Quality & Compliance (Q&C), and the first Chief Quality Officer for Johnson & Johnson, with enterprise leadership responsibility for Q&C, Sterility Assurance and Operations Readiness & Convergence. During this time, she also co-led the design of Johnson & Johnson’s enterprise Supply Chain operating model that ultimately brought together more than twenty disparate groups using core standards and operating principles.
Kathy serves as Chairman of the Board of GS1 Global, an organization that sets and maintains standards regarding the exchange of critical business data. Kathy also sits on the board of the National Association of Manufacturers in the US, and on the advisory board of AWESOME, a nonprofit working on the advancement of women in senior supply chain roles. She is the executive sponsor for Johnson & Johnson’s Women’s Leadership & Inclusion initiative and for Johnson & Johnson’s Women in Science, Technology, Engineering, Math, Manufacturing and Design (WiSTEM2D) program.
In 2019, Kathy was recognized by the Council of Supply Management Professionals (CSCMP) as the recipient of its Distinguished Service Award, the industry’s top individual supply chain honor. In 2015, Kathy received both the National Association of Female Executives’ (NAFE) Women of Excellence Award and the Thinkers & Movers Award for innovative leadership by DSC Logistics. In 2014, Kathy received AWESOME’s Legendary Leadership Award.
Kathy holds a BSE degree in civil engineering and operations research from Princeton University.
This person is not in any offices
Johnson & Johnson
535 followers
Johnson & Johnson and its subsidiaries have approximately 141,700 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. Johnson & Johnson is a holding company, with operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887. Johnson & Johnson is organized into three business segments: Consumer Health, Pharmaceutical and Medical Devices. The Consumer Health segment includes a broad range of products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology (e.g., rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease and psoriasis), Infectious Diseases (e.g., HIV/AIDS and COVID-19), Neuroscience (e.g., mood disorders, neurodegenerative disorders and schizophrenia), Oncology (e.g., prostate cancer, hematologic malignancies, lung cancer and bladder cancer), Cardiovascular and Metabolism (e.g., thrombosis, diabetes and macular degeneration) and Pulmonary Hypertension (e.g., Pulmonary Arterial Hypertension). Medicines in this segment are distributed directly to retailers, wholesalers, distributors, hospitals and healthcare professionals for prescription use. The Medical Devices segment includes a broad range of products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields. At Johnson & Johnson, employees are guided by Our Credo which sets forth the Company’s responsibilities to patients, consumers, customers, healthcare professionals, employees, communities and shareholders. The Company is committed to workplace diversity and to cultivating, fostering, and advancing a culture of equity and inclusion. Enabling employees to perform at their best while being themselves is fundamental to the Company’s continued success. The Company’s DEI vision is: Be yourself, change the world.